Friday, April 26, 2024
Advertisement
  • high court bars glenmark from making anti diabetes drugs

    High Court bars Glenmark from making anti-diabetes drugs

    India | March 20, 2015 20:16 IST

    New Delhi: The Delhi High Court today restrained Indian firm Glenmark Pharmaceuticals from manufacturing, marketing or selling its anti-diabetes drugs Zita and Zita-Met, saying it has "prima facie" infringed the patent of US drug major

Advertisement
Advertisement
Advertisement
Advertisement